A modulatory effect of novel kojic acid derivatives on cancer cell proliferation and macrophage activation

Pharmazie

Volumn 65, Issue 4, 2010, Pages 261-266

  Cho, Jae Youl ^a   Yoo, Dae Sung ^b   Lee, Jaehwi ^b   Choi, Sun Shim ^b   Rho, Ho Sik ^b   Cho, Dong Ha ^b   Shin, Won Cheol ^b  

^a Kangwon National University   (South Korea)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 6; KOJIC ACID; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROTEIN KINASE FYN; PROTEIN KINASE YES; PROTEIN TYROSINE KINASE; RHS 0107; RHS 0108; RHS 0110; RHS 0111; RHS 0112; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; GLIOMA CELL; IC 50; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MACROPHAGE ACTIVATION; MICROENVIRONMENT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; COLORING AGENTS; DNA FRAGMENTATION; GLIOMA; IMMUNOPRECIPITATION; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; NITRIC OXIDE; PYRONES; RATS; TETRAZOLIUM SALTS; THIAZOLES; TOLL-LIKE RECEPTOR 4;

EID: 77950611243     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.9764     Document Type: Article

References (29)

1. Aouacheria A, Neel B, Bouaziz Z, Dominique R, Walchshofer N, Paris J, Fillion H, Gillet G (2002) Carbazolequinone induction of caspasedependent cell death in Src-overexpressing cells. Biochem Pharmacol 64: 1605-1616.
2. Ch'ng S, Tan ST (2009) Genetics, cellular biology and tumor microenvironment of melanoma. Front Biosci 14: 918-928.
3. Cheng GZ, Park S, Shu S, He L, Kong W, Zhang W, Yuan Z, Wang LH, Cheng JQ (2008) Advances of AKT pathway in human oncogenesis and as a target for anti-cancer drug discovery. Curr Cancer Drug Targets 8: 2-6.
4. Cherian PP, Schenker S, Henderson GI (2008) Ethanol-mediated DNA damage and PARP-1 apoptotic responses in cultured fetal cortical neurons. Alcohol Clin Exp Res 32: 1884-1892.
5. Cho JY, Kim AR, Jung JH, Chun T, Rhee MH, Yoo ES (2004) Cytotoxic and pro-apoptotic activities of cynaropicrin, a sesquiterpene lactone, on the viability of leukocyte cancer cell lines. Eur J Pharmacol 492: 85-94.
6. de la Cruz-Merino L, Grande-Pulido E, Albero-Tamarit A, Codes-Manuel deVillenaME(2008) Cancer and immune response: old and newevidence for future challenges. Oncologist 13: 1246-1254.
7. Emami S, Hosseinimehr SJ, Taghdisi SM, Akhlaghpoor S (2007) Kojic acid and its manganese and zinc complexes as potential radioprotective agents. Bioorg Med Chem Lett 17: 45-48.
8. Fickova M, Pravdova E, Rondhal L, Uher M, Brtko J (2008) In vitro antiproliferative and cytotoxic activities of novel kojic acid derivatives: 5-benzyloxy-2-selenocyanatomethyl- and 5-methoxy- 2-selenocyanatomethyl-4- pyranone. J Appl Toxicol 28: 554-559.
9. Fukata M, Hernandez Y, Conduah D, Cohen J, Chen A, Breglio K, Goo T, Hsu D, Xu R, Abreu MT (2009) Innate immune signaling by Tolllike receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm Bowel Dis 15: 997-1006.
10. Han R, Baden HP, Brissette JL, Weiner L (2002) Redefining the skin's pigmentary system with a novel tyrosinase assay. Pigment Cell Res 15: 290-297.
11. Hosseinimehr SJ, Emami S, Zakaryaee V, Ahmadi A, Moslemi D (2009) Radioprotective effects of kojic acid against mortality induced by gamma irradiation in mice. Saudi Med J 30: 490-493.
12. Jennings MT, Sposto R, Boyett JM, Vezina LG, Holmes E, Berger MS, Bruggers CS, Bruner JM, Chan KW, Dusenbery KE, Ettinger LJ, Fitz CR, Lafond D, Mandelbaum DE, Massey V, McGuire W, McNeely L, Moulton T, Pollack IF, Shen V (2002) Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group. J Clin Oncol 20: 3431-3437.
13. Kang SS, Kim HJ, Jin C, Lee YS (2009) Synthesis of tyrosinase inhibitory (4-oxo-4H-pyran-2-yl)acrylic acid ester derivatives. Bioorg Med Chem Lett 19: 188-191.
14. Kang YJ, Min HY, Hong JY, Kim YS, Kang SS, Lee SK (2009) Biomol Ther 17: 282-287.
15. Laszlo GS, Nathanson NM (2003) Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor. J Biol Chem 278: 27750-27757.
16. Lee YG, Chain BM, Cho JY (2009) Distinct role of spleen tyrosine kinase in the early phosphorylation of inhibitor of kappaB alpha via activation of the phosphoinositide-3-kinase and Akt pathways. Int J Biochem Cell Biol 41: 811-821.
17. Lee YG, Lee WM, Kim JY, Lee JY, Lee IK, Yun BS, Rhee MH, Cho JY (2008) Src kinase-targeted anti-inflammatory activity of davallialactone from Inonotus xeranticus in lipopolysaccharide-activatedRAW264.7 cells. Br J Pharmacol 154: 852-863.
18. Li X, Jeong JH, Lee KT, Rho JR, Choi HD, Kang JS, Son BW (2003) Gamma-pyrone derivatives, kojic acid methyl ethers from a marinederived fungus Alternaria [correction of Altenaria] sp. Arch Pharm Res 26: 532-534.
19. Massey V, McGuire W, McNeely L, Moulton T, Pollack IF, Shen V (2002) Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group. J Clin Oncol 20: 3431-3437.
20. Messmer UK, Brune B (1996) Nitric oxide (NO) in apoptotic versus necrotic RAW264.7 macrophage cell death: the role of NO-donor exposure, NAD+ content, and p53 accumulation. Arch Biochem Biophys 327: 1-10.
21. Novotny L, Rauko P, Abdel-Hamid M, Vachalkova A (1999) Kojic acid- a new leading molecule for a preparation of compounds with an antineoplastic potential. Neoplasma 46: 89-92.
22. Pittet MJ (2009) Behavior of immune players in the tumor microenvironment. Curr Opin Oncol 21: 53-59.
23. Schwartsburd PM (2003) Chronic inflammation as inductor of procancer microenvironment: pathogenesis of dysregulated feedback control. Cancer Metastasis Rev 22: 95-102.
24. Silver IA, Deas J, Erecinska M (1997) Ion homeostasis in brain cells: differences in intracellular ion responses to energy limitation between cultured neurons and glial cells. Neuroscience 78: 589-601.
25. Shim JH, Choi CS, Lee EC, Kim MY, Chun YJ (2009) Tamoxifen suppresses clusterin level through Akt inactivation and proteasome degradation in human prostate cancer cells. Biomol Ther 17: 25-31.
26. Uher M, Chalabala M, Cizmarik J (2000) Kojic acid and its derivatives as potential therapeutic agents. Ceska Slov Farm 49: 288-298.
27. Vachalkova A, Bransova J, Brtko J, Uher M, Novotny L (1996) Polarographic behavior of kojic acid and its derivatives, determination of potential carcinogenicity and correlation of these properties with their other attributes. Neoplasma 43: 265-269.
28. Wan HM, Chen CC, Chang TS, Giridhar RN, Wu WT (2004) Combining induced mutation and protoplasting for strain improvement of Aspergillus oryzae for kojic acid production. Biotechnol Lett 26: 1163-1166.
29. Zumsteg A, Christofori G (2009) Corrupt policemen: inflammatory cells promote tumor angiogenesis. Curr Opin Oncol 21: 60-70.